Jennifer Levin Carter

Jennifer is Head of Precision Health at Integral Health. She is a healthcare entrepreneur and executive with particular expertise in precision medicine, digital health and AI. Jennifer has a passion for finding solutions to improve patient care with deep expertise in creation of systems and platforms supporting clinical access to improved diagnostics and therapeutics. She was Founder, President and Chief Medical Officer of N-of-One acquired by Qiagen (MKT Cap $8B); and Founder and CEO of “TZ” acquired by Integral Health, a Flagship Pioneering company.

Jennifer is on the Board of Directors at Target Cancer Foundation. She is a Founding Strategic Board member of XSphera Biosciences, Inc., and on the Director’s Advisory Board at Smilow Cancer Center at Yale University. Jennifer graduated Phi Beta Kappa, Summa Cum Laude with a BS in Molecular Biophysics and Biochemistry from Yale University, an MD from Harvard Medical School, an MPH from Harvard School of Public Health and an MBA from Massachusetts Institute of Technology.